Molecular mechanisms underlying proteinuria reduction and protection of nephrin and podocytes by ARB
Kumagai, H.; Onami, T.; Takimoto, C.; Iigaya, K.; Saruta, T.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 2): 639-646
2006
ISSN/ISBN: 0047-1852 PMID: 16523969 Document Number: 599820
Document emailed within 1 workday
Related Documents
Hino, K.; Nishina, S.; Hara, Y. 2015: Molecular mechanisms underlying iron metabolic disorder in hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 155-159Arutiunian, V.M.; Grigorian, E.G.; Karagezian, K.G.; Vasilian, A.A.; Arutiunian, M.S.; Ovsian, G.A. 1999: Possible explanations of molecular mechanisms underlying etiology and pathogenesis of periodic disease Klinicheskaia Meditsina 77(11): 57-59
Eguchi, T.; Tezuka, T.; Miyoshi, S.; Yamanashi, Y. 2017: Molecular mechanisms underlying the formation and maintenance of neuromuscular junctions and a possible therapeutic approach Clinical Calcium 27(3): 413-419
Bhalla, R.C.; Sharma, R.V.; Aqel, M.B. 1987: Molecular mechanisms underlying increased contractility to norepinephrine stimulation in SHR vascular smooth muscle Progress in Clinical and Biological Research 245: 277-288
Gerlach, M.; Desser, H.; Youdim, M.B.; Riederer, P. 1996: New horizons in molecular mechanisms underlying Parkinson's disease and in our understanding of the neuroprotective effects of selegiline Journal of Neural Transmission. Supplementum 48: 7-21
Surh, Y.J.; Chun, K.S.; Cha, H.H.; Han, S.S.; Keum, Y.S.; Park, K.K.; Lee, S.S. 2001: Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation Mutation Research 480-481: 243-268
Roa, B.B.; Garcia, C.A.; Lupski, J.R. 1991: Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy International Journal of Neurology 25-26: 97-107
Rhim, J.S. 2003: Research into molecular and genetic mechanisms underlying prostate carcinogenesis would be greatly advanced by in vitro prostate cell models Drugs of Today 39(11): 837-847
Costagliola, S.; De Leener, A. 2008: Molecular mechanisms selected by evolution m primates for self-protection against human chorionic gonadotropin Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 163(10-12): 481-484; Discussion: 484-485
Andrews, P.M. 1989: Shape changes in kidney glomerular podocytes: mechanisms and possible functional significance Progress in Clinical and Biological Research 295: 157-166
Corbucci, G.G.; Marchi, A.; Lettieri, B.; Luongo, C. 2005: Mechanisms of cell protection by adaptation to chronic and acute hypoxia: molecular biology and clinical practice Minerva Anestesiologica 71(11): 727-740
Carraro, M.; Zennaro, C. 2006: The pathogenetical mechanisms of glomerular proteinuria Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 23(5): 459-470
McNeilly, A.S.; Tay, C.C.; Glasier, A. 1994: Physiological mechanisms underlying lactational amenorrhea Annals of the new York Academy of Sciences 709: 145-155
Heilman, K.M.; Watson, R.T. 1977: Mechanisms underlying the unilateral neglect syndrome Advances in Neurology 18: 93-106
Poortmans, J.R. 1985: Postexercise proteinuria in humans. Facts and mechanisms JAMA 253(2): 236-240
Lubetzky, M.; Auli, M.J.; Walker, J.; Leeser, D.; Kapur, S.; Hartono, C.; Dadhania, D. 2010: Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection Clinical Transplants 2010: 437-440
Zeevalk, G.D.; Nicklas, W.J. 1991: Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition Journal of Pharmacology and Experimental Therapeutics 257(2): 870-878
Pincelli, C.; Schafer, P.H.; French, L.E.; Augustin, M.; Krueger, J.G. 2018: Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis Journal of Drugs in Dermatology: Jdd 17(8): 835-840
Kohl, R.L.; Lewis, M.R. 1987: Mechanisms underlying the antimotion sickness effects of psychostimulants Aviation Space and Environmental Medicine 58(12): 1215-1218
Heinemann, U.; Kann, O.; Remy, S.; Beck, H. 2006: Novel mechanisms underlying drug resistance in temporal lobe epilepsy Advances in Neurology 97: 85-95